A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer

Clinical trial NCT02131506 · TERMINATED

Trial details

NCT number: NCT02131506
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

HER-2 Positive Breast Cancer Malignant Neoplasm of Breast

Start date: 2009-12-01
Primary completion: 2016-01-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.